Coronavirus Tracker: the Latest Figures
The FT analyses the scale of outbreaks and tracks the vaccine rollouts around the world.

Send us a link
The FT analyses the scale of outbreaks and tracks the vaccine rollouts around the world.
Study finds 34% developed psychiatric or neurological conditions after six months.
The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year.
A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.
His claim that 'greed' was the driver behind the UK's vaccine success ignores the huge role of state funding, says economics professor Mariana Mazzucato.
Did Covid-19 come from animal markets? It's unclear. Did it emerge from a lab? Also unclear. Here's what a new W.H.O. report says - including questions that the agency's own chief raised about the findings.
The pandemic is not a competition between companies and will not end without more-equal distribution of coronavirus vaccines.
For the moment, reports of a very rare, dangerous blood disorder among recipients cannot be ignored.
Scientists say the conclusions make sense but note that supporters of the lab-leak theory are unlikely to be satisfied.
Risks shoot up when virus particles accumulate in buildings, but it's not clear how best to improve ventilation.
PubMed Central articles are an important source of COVID-19 datasets, but there is significant heterogeneity in the way these datasets are mentioned, shared, updated and cited.
A special report outlines the challenges - from unleashing the power of mRNA vaccines, to the battle for temporary intellectual-property relief.
Within the scope of the Career Tracker Cohorts study, postdocs were surveyed in order to learn more about potential changes in their work routines, effects on their research, and their own assessment of the impact the pandemic would have on their careers.
Global study of the effects of COVID-19 on research funding, publishing, and library budgets - the truth we found in the gap between perception and reality
The advancement of science — an intrinsically iterative process — is contingent on reporting practices that enable data to be findable, accessible, interoperable, and reusable to permit independent scrutiny, replication, and follow-on investigations. The urgency associated with the pandemic has created an imperative to accelerate the adoption of open science.
Results confirming the vaccine's strong protection against COVID-19 were welcomed following last week's pause in roll-outs - but fresh questions have now emerged about the data.
A new study illuminates the complex array of neurological issues experienced by people months after their coronavirus infections.
Society deserves academic discourse that is civil, cool, unbiased, and objective - but the Covid-19 pandemic has accentuated an erosion in civility in academic discourse, leading to deep divisions being played out in social, mass, and professional media.
COVID-19 has inflicted devastating losses. It has also delivered certain blessings.
Even with vaccination efforts in full force, the theoretical threshold for vanquishing COVID-19 looks to be out of reach.
As COVID-19 forced professors to embrace digital texts, they were likelier to know about free, openly licensed materials - but not to use them.
Doctors are applying a torrent of COVID-19 research to patient care, from first symptoms to recovery
We asked doctors, scientists, public health experts and health advocates to take a look back - what would they redo, if they could?
At the risk of breaking the Fourth Wall, here's a story about peer reviews that weren't - and shouldn't have been.
Yes, all of the COVID-19 vaccines are very good. No, they're not all the same.
The intervention was the earliest action yet known in an effort by Gov. Andrew M. Cuomo that concealed how many nursing home residents died in the pandemic.